IMC Chicago
TMO icon

IMC Chicago’s Thermo Fisher Scientific TMO Stock Holding History

IMC Chicago’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57.8M Sell
117,600
-15,700
-12% -$8.52M 0.02% 453
2025
Q4 		$77.2M Sell
133,300
-6,000
-4% -$3.39M 0.03% 357
2025
Q3 		$67.6M Buy
139,300
+29,200
+27% +$13.6M 0.02% 372
2025
Q2 		$44.6M Buy
110,100
+15,500
+16% +$6.48M 0.02% 421
2025
Q1 		$47.1M Sell
94,600
-1,300
-1% -$704K 0.03% 337
2024
Q4 		$49.9M Sell
95,900
-12,200
-11% -$6.71M 0.02% 350
2024
Q3 		$66.9M Sell
108,100
-36,300
-25% -$21.5M 0.04% 248
2024
Q2 		$79.9M Buy
144,400
+57,700
+67% +$33.1M 0.05% 207
2024
Q1 		$50.4M Sell
86,700
-15,200
-15% -$8.53M 0.03% 248
2023
Q4 		$54.1M Buy
101,900
+43,100
+73% +$20.9M 0.04% 236
2023
Q3 		$29.8M Sell
58,800
-11,700
-17% -$6.23M 0.03% 298
2023
Q2 		$36.8M Buy
70,500
+1,000
+1% +$540K 0.03% 247
2023
Q1 		$40.1M Buy
69,500
+4,600
+7% +$2.59M 0.05% 207
2022
Q4 		$35.7M Buy
64,900
+18,900
+41% +$10M 0.06% 207
2022
Q3 		$23.3M Buy
46,000
+16,800
+58% +$9.4M 0.03% 256
2022
Q2 		$15.9M Sell
29,200
-9,300
-24% -$5.12M 0.02% 335
2022
Q1 		$22.7M Sell
38,500
-15,700
-29% -$9.02M 0.02% 324
2021
Q4 		$36.2M Sell
54,200
-5,700
-10% -$3.56M 0.03% 262
2021
Q3 		$34.2M Buy
59,900
+8,100
+16% +$4.45M 0.04% 243
2021
Q2 		$26.1M Buy
51,800
+7,100
+16% +$3.35M 0.03% 277
2021
Q1 		$20.4M Buy
44,700
+23,100
+107% +$11M 0.03% 289
2020
Q4 		$10.1M Buy
+21,600
New +$10.1M 0.01% 403

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

IMC Chicago's TMO Position: Q1 2026 in Review

IMC Chicago reduced its Thermo Fisher Scientific (TMO) stake by 74% in Q1 2026, selling an estimated $13.8M and leaving 9,017 shares worth $4.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1878.

IMC Chicago first reported a position in TMO in Q4 2020 and has held it in 7 quarters since. The position peaked at $19.9M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • IMC Chicago held 9,017 shares of Thermo Fisher Scientific worth $4.43M as of Q1 2026.
  • IMC Chicago sold 25,367 Thermo Fisher Scientific shares in Q1 2026, an estimated $13.8M.
  • Thermo Fisher Scientific made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #1878 holding.
  • IMC Chicago first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 7 quarters since.
  • IMC Chicago's Thermo Fisher Scientific position peaked at $19.9M in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.